Skip to main content
Welcome
Register
Certificate of Attendance
Login Required
Survey
Login Required
Download the App
My Experience
Login Required
People
Oral Presenters
Poster Presenters
Delegates
Login Required
Schedule
Daily Schedule
Wednesday, November 1, 2023
Thursday, November 2, 2023
Friday, November 3, 2023
Saturday, November 4, 2023
Author
Title
Posters
Primary Author
Number
Category
Title
Poster Gallery
Login Required
Sponsors
Thank You Sponsors
Visit our Sponsors
Friends of CTOS
Sunrise Mentorship Program
CTOS Networking Events
Networking Events
Gala
Ancillary Events
Patient Advocacy
About SPAGN
SPAGN Events
Things to do in Dublin
Maureen's Dublin
Tour Information
Printable Materials
Schedule at a Glance
Oral Presentations
Login Required
Poster Presentations
Login Required
Hotels
Statement of Conduct
About the Platform
FAQ
Toggle navigation
Login
Search
Home
Welcome
Register
Certificate of Attendance
Login Required
Survey
Login Required
Download the App
My Experience
Login Required
People
Oral Presenters
Poster Presenters
Delegates
Login Required
Schedule
Daily Schedule
Wednesday, November 1, 2023
Thursday, November 2, 2023
Friday, November 3, 2023
Saturday, November 4, 2023
Author
Title
Posters
Primary Author
Number
Category
Title
Poster Gallery
Login Required
Sponsors
Thank You Sponsors
Visit our Sponsors
Friends of CTOS
Sunrise Mentorship Program
CTOS Networking Events
Networking Events
Gala
Ancillary Events
Patient Advocacy
About SPAGN
SPAGN Events
Things to do in Dublin
Maureen's Dublin
Tour Information
Printable Materials
Schedule at a Glance
Oral Presentations
Login Required
Poster Presentations
Login Required
Hotels
Statement of Conduct
About the Platform
FAQ
Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Tweet
Print
José Manuel Asencio, PhD, MD
Department of Surgery, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Spain
Poster(s):
(P 385) FIRST IN HUMAN PHASE I TRIAL OF A NOVEL DRUG DELIVERY IMPLANT MATRIX WITH SN-38 (CEB-01) FOR RETROPERITONEAL SOFT TISSUE SARCOMA
Back to Top